A phase 1 trial of human telomerase reverse transcriptase (hTERT) vaccination combined with therapeutic strategies to control immune-suppressor mechanisms
Article in Experimental Biology and Medicine (January 2024)
The most recent citing publications are shown below. View all 110 publications that cite this research output on Dimensions.
Article in Experimental Biology and Medicine (January 2024)
Article in International Immunopharmacology (January 2024)
Article in Cancer Immunology, Immunotherapy (January 2024)